Literature DB >> 22480751

Effect of bypassing the proximal gut on gut hormones involved with glycemic control and weight loss.

Dimitri J Pournaras1, Erlend T Aasheim, Marco Bueter, Ahmed R Ahmed, Richard Welbourn, Torsten Olbers, Carel W le Roux.   

Abstract

BACKGROUND: The reported remission of type 2 diabetes in patients undergoing Roux-en-Y gastric bypass has brought the role of the gut in glucose metabolism into focus. Our objective was to explore the differential effects on glucose homeostasis after oral versus gastrostomy glucose loading in patients with Roux-en-Y gastric bypass at an academic health science center.
METHODS: A comparative controlled investigation of oral versus gastrostomy glucose loading in 5 patients who had previously undergone gastric bypass and had a gastrostomy tube placed in the gastric remnant for feeding. A standard glucose load was administered either orally (day 1) or by the gastrostomy tube (day 2). The plasma levels of glucose, insulin, glucagon-like peptide 1 and peptide YY were measured before and after glucose loading.
RESULTS: Exclusion of the proximal small bowel from glucose passage induced greater plasma insulin, glucagon-like peptide 1, and peptide YY responses compared with glucose loading by way of the gastrostomy tube (P <.05).
CONCLUSIONS: Exclusion of glucose passage through the proximal small bowel results in enhanced insulin and gut hormone responses in patients after gastric bypass. The gut plays a central role in glucose metabolism and represents a target for future antidiabetes therapies.
Copyright © 2012 American Society for Metabolic and Bariatric Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22480751     DOI: 10.1016/j.soard.2012.01.021

Source DB:  PubMed          Journal:  Surg Obes Relat Dis        ISSN: 1550-7289            Impact factor:   4.734


  26 in total

1.  Effect of bariatric surgery on systemic and adipose tissue inflammation.

Authors:  Valerie G Sams; Camille Blackledge; Nadeeja Wijayatunga; Patrick Barlow; Matthew Mancini; Gregory Mancini; Naima Moustaid-Moussa
Journal:  Surg Endosc       Date:  2015-10-30       Impact factor: 4.584

Review 2.  Preventing type 2 diabetes, CVD, and mortality: surgical versus non-surgical weight loss strategies.

Authors:  D J Pournaras; C W le Roux
Journal:  Curr Atheroscler Rep       Date:  2013-11       Impact factor: 5.113

3.  Metabolic Effect of Foregut Exclusion Demonstrated by the Impact of Gastrogastric Fistula on Recurrence of Diabetes.

Authors:  Pichamol Jirapinyo; Andrew C Thompson; Paul T Kröner; Walter W Chan; Christopher C Thompson
Journal:  J Am Coll Surg       Date:  2017-12-22       Impact factor: 6.113

Review 4.  Bone marrow-CNS connections: implications in the pathogenesis of diabetic retinopathy.

Authors:  Jane Yellowlees Douglas; Ashay D Bhatwadekar; Sergio Li Calzi; Lynn C Shaw; Debra Carnegie; Sergio Caballero; Quihong Li; Alan W Stitt; Mohan K Raizada; Maria B Grant
Journal:  Prog Retin Eye Res       Date:  2012-05-15       Impact factor: 21.198

Review 5.  Review of Advances in Anti-obesity Pharmacotherapy: Implications for a Multimodal Treatment Approach with Metabolic Surgery.

Authors:  Alexis C Sudlow; Carel W le Roux; Dimitri J Pournaras
Journal:  Obes Surg       Date:  2019-12       Impact factor: 4.129

6.  Effects of gastrogastric fistula repair on weight loss and gut hormone levels.

Authors:  Ciaran S O'Brien; Gary Wang; James McGinty; Keesandra K Agénor; Roxanne Dutia; Antonia Colarusso; Koji Park; Ninan Koshy; Blandine Laferrère
Journal:  Obes Surg       Date:  2013-08       Impact factor: 4.129

7.  Evidence from a single individual that increased plasma GLP-1 and GLP-1-stimulated insulin secretion after gastric bypass are independent of foregut exclusion.

Authors:  Marzieh Salehi; Amalia Gastaldelli; David A D'Alessio
Journal:  Diabetologia       Date:  2014-05-06       Impact factor: 10.122

8.  Estradiol modulates the anorexic response to central glucagon-like peptide 1.

Authors:  Calyn B Maske; Christine M Jackson; Sarah J Terrill; Lisa A Eckel; Diana L Williams
Journal:  Horm Behav       Date:  2017-06-01       Impact factor: 3.587

9.  Evolution of glycolipid profile after sleeve gastrectomy vs. Roux-en-Y gastric bypass: results of a prospective randomized clinical trial.

Authors:  Michel Vix; Michele Diana; Keng-Hao Liu; Antonio D'Urso; Didier Mutter; Hurng-Sheng Wu; Jacques Marescaux
Journal:  Obes Surg       Date:  2013-05       Impact factor: 4.129

10.  Long-term results of a prospective comparison of Roux-en-Y gastric bypass versus a variant of biliopancreatic diversion in a non-superobese population (BMI 35-50 kg/m(2)).

Authors:  George Skroubis; Natasa Kouri; Nancy Mead; Fotis Kalfarentzos
Journal:  Obes Surg       Date:  2014-02       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.